These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17402829)

  • 1. Surrogate markers to assess new therapies for drug-resistant tuberculosis.
    Wallis RS
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):163-8. PubMed ID: 17402829
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi drug resistant tuberculosis.
    Githui WA
    East Afr Med J; 2006 Nov; 83(11):585-7. PubMed ID: 17455446
    [No Abstract]   [Full Text] [Related]  

  • 3. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
    Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
    Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical testing of new drugs for tuberculosis: current challenges.
    Lenaerts AJ; Degroote MA; Orme IM
    Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The threat of extensively drug-resistant tuberculosis.
    Mohapatra PR
    Clin Infect Dis; 2007 Mar; 44(6):888-9. PubMed ID: 17304469
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Moulding T
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1102; author reply 1102. PubMed ID: 18713512
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the study of chemotherapy of multidrug-resistant tuberculosis].
    Tang SJ; Xiao HP; Zhang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):617-20. PubMed ID: 19958683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-drug resistant tuberculosis in pregnancy: need for more intensive treatment.
    Tabarsi P; Baghaei P; Mirsaeidi M; Amiri M; Mansouri D; Novin A; Zendedel SM; Masjedi MR
    Infection; 2007 Dec; 35(6):477-8. PubMed ID: 17906837
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective.
    Sacks LV; Behrman RE
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S93-100. PubMed ID: 18762157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence and risk factors of drug-resistant tuberculosis among migratory population in Shanghai, China].
    Shen X; Shen M; Gui XH; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):407-10. PubMed ID: 17673008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.